Childrens Hospital of Eastern Ontario

Ottawa K1H8L1

2 studies enrolling now · 6 studies all time

What they study most

Congenital Heart Disease, Deep Vein Thrombosis, Generalized Myasthenia Gravis, Respiratory Syncytial Virus Infections, Type 1 Diabetes, Venous Thromboembolism, gMG

Studies at this site

• A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis — Recruiting now
• Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis — Enrolling by invitation
• Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home — Completed
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease — Completed